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ABSTRACT
Squalene-based adjuvants have been included in inﬂuenza vaccines since 1997. Despite several
advantages of adjuvanted seasonal and pandemic inﬂuenza vaccines, laypeople’s perception of such
formulations may be hesitant or even negative under certain circumstances. Moreover, in Italian, the term
“squalene” has the same root as such common words as “shark” (squalo), “squalid” and “squalidness” that
tend to have negative connotations. This study aimed to quantitatively and qualitatively analyze a
representative sample of Italian web pages mentioning squalene-based adjuvants used in inﬂuenza
vaccines. Every effort was made to limit the subjectivity of judgments. Eighty-four unique web pages were
assessed. A high prevalence (47.6%) of pages with negative or ambiguous attitudes toward squalene-
based adjuvants was established. Compared with web pages reporting balanced information on squalene-
based adjuvants, those categorized as negative/ambiguous had signiﬁcantly lower odds of belonging to a
professional institution [adjusted odds ratio (aOR) D 0.12, p D .004], and signiﬁcantly higher odds of
containing pictures (aOR D 1.91, p D .034) and being more readable (aOR D 1.34, p D .006). Some
differences in wording between positive/neutral and negative/ambiguous web pages were also observed.
The most common scientiﬁcally unsound claims concerned safety issues and, in particular, claims linking
squalene-based adjuvants to the Gulf War Syndrome and autoimmune disorders. Italian users searching
the web for information on vaccine adjuvants have a high likelihood of ﬁnding unbalanced and
misleading material. Information provided by institutional websites should be not only evidence-based
but also carefully targeted towards laypeople. Conversely, authors writing for non-institutional websites
should avoid sensationalism and provide their readers with more balanced information.
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Introduction
Let us consider the following Italian word family: squalo, squal-
lido and squallore. While the ﬁrst word means “shark”, the
other two both have negative referential meaning (cf. “squalid”
and “squalidness”). This word family derived from the Latin
adjective squalidus, derived in turn from the verb squalere that
means “to be dirty/rough”. While the English “squalid” and
“squalidness” may be considered as learned terms, the Italian
counterparts are rather common. The term “squalene” also
comes from the same Latin root since this natural compound
was ﬁrst isolated from the shark liver oil. The denotative
(i.e. literal) meaning of squalene may be described as follows: a
natural unsaturated 30-carbon polyprenyl compound playing
the key role in cholesterol biosynthesis.1,2 On the other hand,
because the term “squalene” is unfamiliar to most laypeople, its
connotative (i.e. emotionally charged) meaning would likely be
negative through associative analogies with the Italian words
squalo, squallido and squallore.
Nowadays, squalene has various uses. Mostly, it is widely
employed by the cosmetic industry because it has properties
which make skin smooth and elastic.3 Squalene may also be
considered a potential natural chemopreventive substance;
indeed, in the Mediterranean diet – the advantages of which
are internationally recognized – daily intake of squalene may
reach up to 400 mg, mainly due to the intake of olive oil. By
contrast, in other countries, such as the US, its intake is only
around 30 mg.4 Squalene and shark liver oil are also popular
dietary supplements.5 And ﬁnally, squalene-oil-in-water emul-
sions (e.g. MF59, AS03, AF03) have widely been used as
vaccine adjuvants since 1997. The major beneﬁts of including
squalene-based adjuvants in vaccine formulation are: enhanced
immunogenicity; more rapid antibody responses; more persis-
tent antibody responses; enhanced heterologous antibody
responses; and the possibility of antigen dosage sparing, which
is crucial during emergencies such as inﬂuenza pandemics. Sea-
sonal inﬂuenza vaccines adjuvanted with MF59 have been
widely used to immunize elderly individuals for the last
20 years. Both MF59 and AS03 were components of the
2009 H1N1 pandemic vaccines used in all age groups.6-9
Despite the aforementioned advantages of squalene-based
adjuvants, their widespread use generated various scientiﬁcally
unsound claims and myths (these are described in the Methods
section). In Italy, which was the ﬁrst country where MF59-
adjuvanted inﬂuenza vaccine was authorized, such myths were
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somewhat reinforced by the etymology of the word “squalene”
described earlier. A further challenge occurred in late 2014 when
the Italian Medicines Agency suspended two batches of the
MF59-adjuvanted seasonal inﬂuenza vaccine as a precaution-
ary measure following three post-vaccination deaths. Although,
following an investigation, the vaccine complied with all existing
standards and no causal association was found, this event gave
rise to several consequences including unprecedented clamor in
both traditional media and internet, “epidemic of panic”, general
increase in mistrust in vaccines and vaccine hesitancy, (con-
sequent?) decrease in the inﬂuenza vaccination coverage rate,11,12
as well as a “reawakening” of early myths around squalene and
adjuvants. Although this false alarm evolved in a short time
frame, its repercussions were long-term and persist even until
today. Indeed, both traditional and new media are powerful
means of amplifying inaccurate scientiﬁc information, undermin-
ing conﬁdence in vaccines and reducing vaccination coverage.
Probably the best-known example of this phenomenon is pro-
vided by the Wakeﬁeld case: the widespread media coverage of
an alleged link between measles-mumps-rubella (MMR) vaccina-
tion and autism led to a dramatic drop in the uptake of this vac-
cine and an increase in the number of measles cases reported.13
In the United Kingdom, it took more than ten years to restore
the MMR coverage rate to the pre-Wakeﬁeld level.14
Because the internet is one of the main sources of health-
related information,12 it is widely used by anti-vaccination acti-
vists to disseminate misleading information on immunization,15
and the fact that anti-vaccination websites are highly prevalent on
the Italian web16 and may be highly ranked by the common
search engines,17 we hypothesized there to be a high frequency of
web-pages critical to squalene and squalene-based adjuvants
among Italian online resources.
The major goal of the present study was to quantitatively
and qualitatively analyze a representative sample of squalene-
related Italian web pages.
Results
Of 2,550 web pages screened, 2,280 were removed as duplicates.
Of 270 texts assessed, 141 met the inclusion criteria (5 and 123
web pages had no reference to inﬂuenza and squalene in inﬂu-
enza vaccines, respectively, while one page was not accessible).
Subsequently, 2, 7, 33 and 15 web pages were excluded meeting
exclusion criteria 1–4, respectively. In total, 84 web pages were
included in the analysis.
Forty of 84 web pages [47.6% (95% CI: 36.6–58.8%)] were cate-
gorized as negative or ambiguous (Neg/Amb), while the
remaining 44 [52.4% (95% CI: 41.2–63.4%)] as positive or neu-
tral (Pos/Neu). Table 1 reports the main characteristics of the
included web pages, broken down by the general tone. The top-
level domain “.it” largely prevailed among both Pos/Neu and
Neg/Amb web pages; no statistically signiﬁcant difference (x2(3)
D 1.92, p D .59) between the distributions of top-level domains
among Pos/Neu and Neg/Amb web pages was established. By
contrast, many more (5.8-fold difference; x2(1) D 12.02,
p<.001) Pos/Neu web pages belonged to the category of institu-
tional web sources; the effect size was medium (’ D 0.38). In
comparison with Pos/Neu web pages, more than double (x2(1)
D 12.50, p<.001) of those categorized as Neg/Amb had at least
one picture with a medium effect size (’ D 0.39). Analogously,
the Mann-Whitney test highlighted that the distribution in the
absolute number of pictures between Pos/Neu and Neg/Amb
was not identical (p <. 001) with a medium effect size
(r D 0.38). On the basis of the main topic, pictures were catego-
rized into 6 classes, namely images representing the vaccination
process, syringes, vaccine packaging, the inﬂuenza virus,
sharks/monsters, other.
The distribution of single picture categories broken down by
general tone is reported in Table 2; Neg/Amb pages presented
more frequently images of syringes, viruses and sharks/monsters.
However, no statistically signiﬁcant difference between Pos/Neu
and Neg/Amb web pages emerged (Fisher’s exact test: pD .19).
Only 3 web pages had video material (one video each): two
videos contained interviews with anti-vaccination activists,
while the third had an interview with a Hollywood star on vac-
cine-related topics. Due to the paucity of videos, these were not
analyzed quantitatively.
With regard to the readability properties, Pos/Neu web
pages could be judged to be more (jtj(82) D 4.33, p <. 001)
difﬁcult to read than Neg/Amb pages with a large effect size of
jdj D 0.95 (95% CI: 0.49–1.40). Indeed, all 11 web pages with a
GulpEase index < 40 were Pos/Neu (Fisher’s exact test:
p <. 001). The frequency of commonly used words was also
higher (jtj(82) D 2.45, p D .017) in the Neg/Amb category web
pages with a medium effect size (jdj D 0.53).
The adjusted logistic regression model showed that web
pages belonging to the Neg/Amb category had signiﬁcantly lower
odds of having an institution as a source, and signiﬁcantly higher
odds of having at least one picture and being more readable, as
measured by the GulpEase index (Table 3).
Table 1. Characteristics of the web pages analyzed, by general tone.
Variable Level Positive/neutral (N D 44) Negative/ambiguous (N D 40)
Top-level domain, % (95% CI) .it 72.7 (57.2–85.0) 60.0 (43.3–75.1)
.com 6.8 (1.4–18.7) 10.0 (2.8–23.7)
.org 11.4 (3.8–24.6) 12.5 (4.2–26.8)
Other 9.1 (2.5–21.7) 17.5 (7.3–32.8)
Website source, % (95% CI) Institutional 43.2 (28.3–59.0) 7.5 (1.6–20.4)
Non-institutional 56.8 (41.0–71.7) 92.5 (79.6–98.4)
Web pages with at least 1 picture, % (95% CI) — 34.1 (20.5–50.0) 75.0 (58.8–87.3)
Number of pictures, median (range) — 0 (0–3) 1 (0–8)
GulpEASE index, mean (SD) — 42.9 (3.7) 46.4 (3.6)
Common words, % (SD) — 73.6 (5.3) 76.3 (4.7)
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The terms vaccin, squalene, inﬂuenza and adjuvant were
the most common words among both Pos/Neu and Neg/Amb
web pages. However, relative to the most frequent word
vaccin, Neg/Amb pages used the root squalene about twice as
much as Pos/Neu pages (ratios squalene to vaccin of 0.41 and
0.23 for Neg/Amb and Pos/Neu web pages, respectively). Other
particular features of Neg/Amb web pages included (i) higher
weights for the words gulf, war, syndrome, soldier, adverse, min-
ister, government; (ii) higher usage of registered trademarks(e.g.
Novartis, Fluad) and (iii) equal weight for the words health
and death (Fig. 1).
The most prevalent claims reported in Neg/Amb web pages
were those relating squalene or squalene-based adjuvants to the
Gulf War Syndrome (52.5%) and autoimmune pathologies
(47.5%). About a third (35.0%) of web pages dealt with conspir-
acy theories around squalene and/or squalene-based adjuvants.
Other less common claims included safety concerns (27.5%),
direct link to deaths (20.0%), and efﬁcacy concerns (5.0%)
(Table 4). In addition, one web page claimed that squalene causes
infertility, while another linked the use of squalene with autism.
Discussion
The main ﬁnding of the present study is that web pages critical
to squalene-based adjuvants are highly prevalent on the Italian
web: a typical internet user has an equal chance of ﬁnding reli-
able and unreliable information on squalene-based adjuvants.
As shown by Google Trends,18 in the past 5 years web searches
around squalene peaked in the period from 23 November to
6 December 2014 (results not shown) and thus correspond
exactly to the time in which two batches of MF59-adjuvanted
vaccine were blocked in Italy as a precautionary measure.11
Considering Italy’s relatively large current market share of
MF59-adjuvanted vaccine,19 the inadequate information on
squalene may have contributed to the subsequently observed
decrease in vaccination coverage. Proof of this may be found in
the fact that, in a single year the vaccination coverage among
the Italian elderly population decreased by 12.3% (inﬂuenza
vaccination coverage among elderly Italians of 55.4% and
48.6% in the seasons 2013–14 and 2014–15, respectively).20 As
we noted above, such situations undoubtedly have long-term
consequences: from inﬂuenza season 2014–15 to 2015–16 the
vaccination coverage increased by only 1.3 percentage points20
(somewhat like “easy to lose, hard to regain”).
Undoubtedly, unreliable information obtained from
the internet, which is the main source of health-related
information,12 contributed to the observed drop in vaccine
uptake. Returning to the notorious Wakeﬁeld case, it has been
shown that sensational news reports (both traditional and
online) linking the MMR vaccine to autism, which often
recounted the emotional and dramatic stories of parents,
aroused greater interest than those which simply provided fac-
tual information from scientiﬁc studies.21 More recently, a situ-
ation somewhat similar to the Italian “Fluad case” arose in
China22; after some infant deaths had allegedly been linked to
vaccination against hepatitis B, the vaccine in question was
recalled by the authorities. Although no causal association was
ever established, many parents refused to have their children
vaccinated. Again, the primary source of parental information
on the issue was the internet.22 Indeed, it was experimentally
documented23 that people exposed to negative online informa-
tion on a vaccine express less intention to be immunized.
We then established that the website source, level of read-
ability, and number of images are all independent predictors of
the general tone of squalene-related web pages. Non-institu-
tional websites showed an 8.6-fold increase in belonging to the
category of Neg/Amb pages. This ﬁnding was expected and it is
in line with previous Italian research. In particular, all institu-
tional websites analyzed by Poscia et al.24 were pro-vaccination,
while Tozzi et al.25 have found that web pages from govern-
mental agencies and universities had the highest level of credi-
bility concerning human papillomavirus immunization.
Pos/Neu web pages had on average longer words and senten-
ces that reduced their readability. Indeed, more than a quarter of
them could even be judged to be difﬁcult to read for people with
a high school diploma, while no such pages were found in the
Neg/Amb category. A similar pattern has been observed by
Table 2. Categories of images, by general tone.
Category Positive/neutral, N Negative/ambiguous, N
Vaccination 7 6
Syringe 2 10
Vaccine 3 6
Virus 0 4
Sharks/monsters 0 3
Other 9 29
Table 3. Multivariable logistic regression to predict the general tone of web pages
analyzed.
Variable aOR 95% CI p
Website source (institutional vs non-institutional) 0.12 0.03–0.50 .004
N of pictures (1-unit increase) 1.91 1.05–3.48 .034
GulpEASE index (1-unit increase) 1.34 1.09–1.65 .006
% common words (1-unit increase) 1.01 0.88–1.16 .89
Figure 1. Tag clouds with 50 or more common words found among positive/neutral (A) and negative/ambiguous (B) web pages.
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Japanese researchers: in comparison with anti-inﬂuenza immuni-
zation online messages, those pro-inﬂuenza immunization were
harder to read.26 More generally, the readability of squalene-
related web pages is close to those of informed consent forms
written in Italian (mean GulpEase index of 45.7).27
Neg/Amb web pages combined different content forms
more frequently. In particular, they used a relatively high num-
ber of images that could improve the intelligibility of the text
since the denotative meaning of the term “squalene” is rather
technical. According to a theory developed by Boles,28 words
like “squalene” have a high level of concreteness (it is a “thing”)
but low familiarity (extremely low frequency of word usage
and exposure) and imageability (i.e. hard to visualize). Accom-
panying the text with pictures will undoubtedly improve image-
ability. In cases where the referential meaning of squalene
was not given (and even if given this would not be fully com-
prehended by most users) or was twisted, a text containing
emotionally charged images (such as needles and sharks with
bloody teeth, as frequently found among Neg/Amb pages) may
generate or reinforce negative connotations of squalene, adju-
vants, and inﬂuenza vaccines in general among people unfamil-
iar to the topic. Notably, Kata15 has reported that images of
scared needles are a frequent graphical attribute used by the
anti-vaccination movement on the web.
From the point of view of word frequency, it emerged that
Pos/Neu web pages had a relatively higher focus on vaccination
itself and aspects relative to health. By contrast, Neg/Amb
web pages exploited more the unfamiliar word “squalene”,
politically-related words (conspiracy theories),15 names of
major vaccine manufacturers and other registered trademarks
(could be ascribable to the so-called “Big Pharma conspiracy
theory)”29 and accentuated fatal risks (a high usage of the word
“death”). The observed differences in quantitative language led
us to analyze Neg/Amb pages in a more detailed way.
Despite the fact that: the etiology of Gulf War Syndrome/Ill-
ness remains largely uncertain to epidemiologists (it even has
no universally adopted deﬁnition)30; most people have anti-
squalene antibodies31-33; and no Gulf War veterans received
Table 4. Claims around squalene and/or squalene-based adjuvants found among negative/ambiguous web pages.
Myth % 95% CI
Squalene is a toxic/unnatural substance 22.5 10.8–38.5
Efﬁcacy of inﬂuenza vaccines with squalene-based adjuvants is not demonstrated 5.0 0.6–16.9
Too little/no safety data on squalene-based adjuvants are available; there are more risks than beneﬁts regarding squalene-based adjuvants 27.5 14.6–43.9
Squalene and/or squalene-based adjuvants are/may be directly linked to deaths 20.0 9.1–35.6
Squalene and/or squalene-based adjuvants (may) cause autoimmune disorders 47.5 31.5–63.9
Squalene and/or squalene-based adjuvants (may) cause the so-called Gulf War Syndrome 52.5 36.1–68.5
Conspiracy theories around squalene and/or squalene-based adjuvants 35.0 20.6–51.7
Table 5. Myths and facts about squalene and squalene-based adjuvants in inﬂuenza vaccines.
Myths Facts Ref.
Squalene is a toxic/unnatural substance Squalene is a fully biocompatible and biodegradable substance, being the direct predecessor
of cholesterol. About 1 g of squalene is synthetized daily in the human liver and is also
introduced through the normal diet. A considerable amount of squalene can be found in
human sebum and it is largely used by the cosmetic industry.
54,55
Efﬁcacy of inﬂuenza vaccines with squalene-based
adjuvants is not demonstrated
Several meta-analyses have shown that inﬂuenza vaccines containing squalene-based
adjuvants (such as MF59) are both immunogenic and efﬁcacious in preventing inﬂuenza
and its complications.
56-58
Too little/no safety data on squalene-based adjuvants
are available; there are more risks than beneﬁts
regarding squalene-based adjuvants
Tens of clinical and observational studies as well as systematic reviews/meta-analyses have
shown an acceptable safety proﬁle of MF59-adjuvanted inﬂuenza vaccine. Although in
comparison with non-adjuvanted vaccines, there is some increase in the frequency of
solicited adverse events (particularly local reactions), most of which are mild. On the other
hand, the frequency of unsolicited and serious adverse events tend to be lower among
recipients of MF59-adjuvanted vaccine than among those receiving conventional
inﬂuenza vaccines. Moreover, to date, MF59-adjuvanted vaccine is licensed in about 30
countries and more than 100 million doses were administered worldwide from 1997 to
date.
56,59
Squalene and/or squalene-based adjuvants
are/may be directly linked to deaths
This myth probably comes from the so-called “Fluad case” when during the 2014–15 season 3
deaths occurred within 48 hours from vaccination with MF59-adjuvanted inﬂuenza
vaccine. As a result two batches of the vaccine were recalled as a precautionary measure.
No causal link was later established. Moreover, it has been calculated that up to 20 Italian
people die every day within 48 hours of vaccination by pure chance.
10,11
Squalene and/or squalene-based adjuvants
(may) cause autoimmune disorders
In a large (N D 27,998) safety database, no signiﬁcant difference in terms of adverse events of
potential autoimmune origin between people immunized with MF59-adjuvanted vaccine
and those immunized with unadjuvanted vaccines has been found.
59
Squalene and/or squalene-based adjuvants (may)
cause the so-called Gulf War Syndrome
In 2000, American researchers reported data on a high frequency of the presence of anti-
squalene antibodies among veterans with the so-called Gulf War Syndrome. The
methodology of that study was criticized and, according to the US Federal Government,
vaccines administered to military personnel in that period of time did not contain squalene.
Anti-squalene antibodies are very frequently detectable (at low titers) among people never
immunized with vaccines containing squalene. No casual association between positivity to
squalene and the development of GWS has been established. The MF59-adjuvanted
vaccine does not induce anti-squalene antibodies nor increase the quantity of pre-existing
anti-squalene antibodies.
31-34,
60,61
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squalene-adjuvanted vaccine,33,34 the thesis that squalene is a
causative agent of the syndrome and other autoimmune disor-
ders is highly prevalent. Indeed, 60% of Neg/Amb web pages
made such claims. Other safety concerns were also frequently
mentioned. To analyze and discuss the observed phenomena, it
is useful to look at squalene-based adjuvants as “one more
unnatural vaccine ingredient” and then make some parallels
with preservatives and other additives used by the food indus-
try. Consumers are very concerned about food additives, poorly
informed about preservatives, colorants, and artiﬁcial sweet-
eners, and have difﬁculties in understanding the subject of food
chemicals.35 Dickson-Spillmann et al.36 have shown that the
risk perception of food chemicals was positively correlated with
preference for natural food. By analogy, anti-vaccination acti-
vists are frequent supporters of herbalism, veganism, homeopa-
thy, naturopathy and similar practices.15
This study has both strengths and limitations. There are basi-
cally two strengths: one, the methodology of the study accurately
mimics the typical online browsing and search behavior of mem-
bers of the general public, and therefore, the web pages analyzed
are highly representative of real life scenarios, and two, the multi-
dimensional vision of the study outcome. In particular, through-
out the Introduction to Discussion sections of this manuscript,
we have highlighted issues around squalene-based adjuvants
from the perspectives of linguistics, vaccinology and immunol-
ogy, and public health. The main drawback is the subjective
nature of our judgements. Obviously, the authors of this manu-
script are experts in vaccinology; however, every effort was made
to ensure that the investigators’ personal attitudes towards the
web pages analyzed did not bias the outcomes and conclusions of
the study (e.g. by simplifying and standardizing the rules of clas-
siﬁcation, etc.). Undoubtedly, a 4-category classiﬁcation of the
general tone of the web page would have allowed us to provide a
more detailed description of the information available. In this
regard, the use of automatic analyzers of tone and emotion
(enabling the variable to be expressed on a continuous or at least
multi-category scale) may unveil other important associations,
and thus should be considered in future research.
Conclusions
This study makes a comprehensive and multidiscipline analysis
of the information available online to Italian internet users (about
75% of the Italian population) concerning squalene-based vac-
cine adjuvants.37 Negative, unbalanced, and misleading informa-
tion was very common; this is potentially dangerous from a
Public Health point of view. Unproven claims that inﬂuenza vac-
cines enhanced with squalene-based adjuvants may cause Gulf
War Syndrome, autoimmune disorders, and even death, most
likely originate from mass media reports, which are later reposted
and/or re-elaborated to some degree by vaccine-critical websites,
whose presence is high on the Italian web. In future, the mass
media must be very cautious in choosing between legitimate con-
cerns and sensationalism,38 in order to avoid such false alarms
and the propagation of misinformation.
Undoubtedly, inﬂuenza vaccination must be an informed indi-
vidual choice. In the web 2.0 era this choice is highly inﬂuenced by
online resources. Indeed, more than 80% of US healthcare practi-
tioners claim to have had at least one patient who brought
internet-acquired health information to a visit in order to ask the
physician’s opinion on the matter in question.39 Considering the
well-known phenomenon of patient-doctor information asymme-
try, in cases where patients bring web-acquired material on squa-
lene-based adjuvants, the role of physician becomes crucial in
informing the patient about all beneﬁts and risks of such vaccine
formulations. Such provision of information by physicians will
undoubtedly help to reassure those hesitant to be vaccinated. Gov-
ernmental public health agencies and healthcare professionals need
to provide reliable, easily accessible and user-friendly information
on any given health technology. For instance, given the wide avail-
ability of readability formulas in common word processors, gov-
ernmental public health agencies and healthcare professionals
should make greater use of such tools in order to deliver material
that is not only evidence-based but also well-targeted to its poten-
tial readers. Indeed, it has been demonstrated that an accurate revi-
sion of an informed consent form may on average increase the
GulpEase index by 84%.27 Analogously, considering the niche
nature of the topic of squalene-based adjuvants used in inﬂuenza
vaccines, balanced evidence-based texts should be accompanied by
neutral/positive and self-explanatory images, animations or, better
still, video testimonials with relevant stakeholders or celebrities
(indeed, testimonials of anti-vaccination celebrities are rather com-
mon among websites critical of immunization). Moreover, in our
previous experience with a healthcare prevention-oriented mobile
application and a sister website,40,41 we realized that expert-based
opinion on the content, usability and other quality attributes may
differ from the expectations of lay users. Active collaboration
between institutions and potential users, patient organizations, etc.
would therefore help to deliver consumer-focusedmessages.
By contrast, authors contributing to non-institutional websites
should communicate science in a more ethical way. Indeed,
according to the Society of Professional Journalists’ code of
ethics,42 a journalist should “be accurate and fair”, “verify infor-
mation before releasing it”, “take special care not to misrepresent
or oversimplify… a story”, “…update and correct information”,
“balance the public’s need for information against potential
harm”, “consider the long-term implications”, etc.
In our opinion, given that a growing body of literature sug-
gests that the internet is a main driver of vaccination-related
decision-making and the fact that we are living in the “post-
truth era”,43 future studies should shift from purely observa-
tional to implementation research that is able to efﬁciently
inform public policies.
To conclude, despite thousands of deaths avoided and
millions of Euro spared during the last 20 years of squalene-
adjuvanted inﬂuenza vaccine use,44 misinformation on this nat-
urally occurring substance with an “unhappy” etymological
origin makes it a victim of its name.
Methods
Search strategy and eligibility criteria
A set of queries containing a squalene-related plus inﬂuenza-
and/or vaccine-related terms was created (LA and DA); this
considered various semantically close terms, grammatical num-
bers, spellings and suggestions made by the Google autocom-
plete service. In all, 85 queries were created. No explicit
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Boolean operators (such as “AND” or “OR”) were used since
most laypeople and healthcare professionals (HCPs) do not
use/are unable to use these functions.45-47 We were aware that
such a search strategy would have a low speciﬁcity and be more
time-consuming, with queries being very similar and therefore
having a large amount of duplicate results. We, however, opted
for this methodology in order to align with the web searching
behavior of the typical user and thus identify as much highly
ranked squalene-related web pages as possible.
Google was used to locate web pages, because Google is the
most widely used search engine in Italy48 with a market share
of approximately 95%.49
For each query the ﬁrst 30 search results (ﬁrst 3 pages) were
consulted since most users do not go beyond this point.46,50 In
total, 2,550 search results were screened. The search was per-
formed over 4 consecutive days (from 9 to 12 January 2017).
Once duplicates were removed, the selected web pages
were screened in order to identify those potentially eligible
for analysis. The following inclusion criteria were applied:
(i) page availability on the search day; (ii) pages written in
Italian; (iii) inﬂuenza vaccines as one of the main topics of
the web page; (iv) any reference to squalene in inﬂuenza
vaccines (and not in cosmetics, foods etc.). The exclusion
criteria were: (i) no textual information (e.g. only pictures);
(ii) small amount of text (<150 words); (iii) highly techni-
cal material (e.g. articles published in scientiﬁc journals,
operating protocols, manuals) targeting HCPs and scientists;
(iv) forums, chatrooms and similar.
Analysis of web pages and text mining
Each included web page was analyzed by two investigators
(LA and DA) each working independently. All web pages
included were static (i.e. content did not change) during the
period of retrieval. The general tone of an article, which was
the main outcome of the present study, was a priori thought
to be categorized as either positive (those approving of squa-
lene-based adjuvants), neutral (those that neither approve nor
disapprove of squalene-based adjuvants), negative (those disap-
proving of squalene-based adjuvants), or ambiguous (those
containing both approving and disapproving messages).51 The
deﬁnition of each category was discussed and comprehended
by the two raters. However, in the phase of content analysis,
distinguishing between the positive and neutral tones was still
deemed subjective (Cohen’s k 0.60), therefore these two catego-
ries were combined for the purpose of analysis. Moreover, most
web pages that could be potentially categorized as “ambiguous”
reported some scientiﬁcally sound facts on squalene/squalene-
based adjuvants, but at the same time raised suspicions regard-
ing safety issues of such adjuvants (Cohen’s k 0.55). Following
discussion inside the research team and after consultation with
external experts, it was agreed that any uncertainty regarding
squalene/squalene-based adjuvant safety issues would
negatively affect laypeople’s perception, and therefore, the
“negative” and “ambiguous” categories should be combined.
The re-categorization allowed us to have a perfect interrater
agreement. A similar categorization (pro/neutral vs adverse) of
websites on inﬂuenza vaccination has been previously
reported.52 The applied dichotomous rule (i.e. Pos/Neu and
Neg/Amb) in the web page categorization undoubtedly allowed
us to increase the classiﬁcation accuracy.
The top-level domain of each web page included for analy-
sis was extracted and categorized as follows: .it, .com, .org,
and “other”. Furthermore, web pages were dichotomized by
website source into the following categories: (1) governmental
agencies/institutions/universities/hospitals/local health units/
medical centers/HCP societies (henceforth referred to as
“institutional source”) and (2) online newspapers/news sour-
ces/informational portals/users’ generated content (e.g. blogs)
(henceforth referred to as “non-institutional source”). We
assumed that the ﬁrst category, being composed of institutions
and therefore more “ofﬁcial”, would present more reliable
information on squalene/squalene-based adjuvants. Indeed, it
has been shown that the quality of Italian vaccination-related
websites belonging to the government or professional associa-
tions is on average higher than that of blogs and anti-vaccina-
tion movement websites.16
To assess the readability properties of the selected squalene-
related online resources, the GulpEase index53 – speciﬁcally
designed for the Italian language – was applied. The index con-
siders the average number of characters per word, the average
number of words per sentence, and is expressed as 89C[(300 £
NSentence)–(10 £ NLetter)/NWord]; a higher score implies greater
readability. It is usually considered that texts with an index
<40 would be difﬁcult to read for people with a high school-
level educational background. For the automatic readability
assessment, which was carried out using Microsoft Word soft-
ware, each selected article was preliminarily pre-treated in
order to avoid misleading results. In particular, since identiﬁca-
tion of the sentence end performed by the automatic algorithm
is triggered by the presence of punctuation marks relative to
the end sentence (e.g. period, exclamation mark, question
mark), such punctuation marks (eventually found in the middle
of sentences, numbers, abbreviations) were deleted. In the
same way, phrases without the end of sentence punctuation
were also removed from the score calculation.
Other than text, content forms including images and video
also quantiﬁed and were qualitatively described.
In the qualitative part of the analysis, the lexicon of Pos/Neu
and Neg/Amb web pages was compared by constructing and
visually inspecting tag clouds with 50 or more common words.
Subsequently, we analyzed the content of Neg/Amb web pages
in a more detailed way. In the pilot study, we retrieved the ﬁrst
30 web pages using the search terms “squalene” and “inﬂuenza
vaccines” in order to establish main scientiﬁcally unsound infor-
mation on the squalene-based adjuvants in inﬂuenza vaccines.
Six common myths were identiﬁed. Such ﬂawed statements
together with evidence-based information belying these myths
are reported in Table 5.10,11,54-61 Moreover, some conspiracy the-
ories, which are common among anti-vaccination activists,15
around squalene and/or squalene-based adjuvants were also
present. In particular, in the pilot study we identiﬁed two such
statements: (i) “politicians are personally immunized with non-
adjuvanted vaccines, while laypeople are immunized with vac-
cines containing squalene” and (ii) “the only reason to include
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squalene in vaccines is for proﬁt, by sparing the amount of anti-
gen and selling adjuvanted vaccines for a higher price.”
It should be noted that we did not analyze anything other
than squalene-related information (i.e. general immunization-
related claims made by anti-vaccination activists were not ana-
lyzed, nor were quality aspects of the selected web pages since
these topics had been already extensively studied in both Italian
and international contexts). Individuals interested in the com-
mon claims made by anti-vaccination websites may wish to
study the work of Kata et al.15 The quality of Italian vaccina-
tion-related websites is assessed in work by Tafuri et al.,16 while
the quality of information concerning inﬂuenza prevention on
Italian and English websites is described by Maki et al.62
Statistical analysis
Approximately normally distributed variables were expressed
as means with standard deviations (SDs), while ordinal as
medians with ranges. Categorical variables were expressed as
proportions with 95% conﬁdence intervals (CIs). Differences in
approximately normally distributed variables were evaluated by
means of the t test, while those ordinal by means of the Mann-
Whitney U test. Categorical variables were compared by means
of x2 or Fisher’s exact test (whichever test was most appropri-
ate). The effect size for normally distributed data was measured
by means of Cohen’s d, that for the Mann-Whitney U test
– as r D z/xN, while that for 2 £ 2 contingency tables – as ’
D xx2/N. Cohen’s d was interpreted as small (0.2), medium
(0.5), and large (0.8), while r and ’ – as small (0.1), medium
(0.3), and large (0.5).63-65
To establish a statistical association between the main study
outcome (general tone of a web page, where Neg/Amb is 1) and
independent variables of interest, a multivariable logistic
regression model was constructed. Variables showing an associ-
ation with the general tone at a < 0.25 in the univariable analy-
sis were included in the multivariable model.66
All analyses were performed in the R environment.67
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